Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

Westin Testifies to Senate Finance Committee on Cancer Drug Shortage

December 5th 2023

Shortages of several anticancer drugs continue to negatively impact clinicians’ ability to deliver the best possible care to patients.

New Developments in MPN Management Provide Additional Options for Patients

December 5th 2023

Significant progress has been made in terms of understanding myeloproliferative neoplasms and developing treatment strategies to combat them.

AON Joins Nasdaq to Further Patient-Centric Community Oncology Care

November 25th 2023

The American Oncology Network has started trading on Nasdaq with the goal of continuing the growth of the organization.

Administrative Payment Tasks Could Be Causing Detrimental Effect of Treatment Delays and Nonadherence for Patients With Cancer

November 15th 2023

A possible cause of some of the cost-related delays and nonadherence to treatment that patients with cancer and cancer survivors experience could be the time and effort they are forced to spend on administrative payment tasks related to their care.

Providing Timely Cancer Care Access Is Crucial Amid Growing Patient Volume

October 31st 2023

A closer look at some of the approaches being used across The US Oncology Network to improve patient access can provide helpful insight into how practices can meet the growing need for their services.

Data Reveal Medicaid Expansion May Result in Mortality Rate Reductions for Patients With Cancer

October 24th 2023

As a result of the Affordable Care Act’s Medicaid expansion, positive trends are becoming apparent regarding mortality rates for patients with cancer living in the states that have adopted Medicaid expansion.

Majority of US Cancer Centers Report Shortages of Cisplatin/Carboplatin Chemotherapy

June 7th 2023

A survey conducted by the National Comprehensive Cancer Network Best Practices Committee found that 93% of United States cancer centers polled in the report are experiencing a shortage of carboplatin, and 70% currently have a shortage of cisplatin.

Colocation Approach Leads to Decreased Time to Diagnosis, Stimulates Clinician Collaboration

May 30th 2023

Investigators at Dana-Farber Cancer Institute in Boston, Massachusetts, developed a clinical outreach program combining diagnostic and patient navigation services.

CAR T-Cell Therapy Leads to Shorter Hospital Stays, Lower Nonpharmacy Costs Despite High Overall Cost

April 7th 2023

CAR T-cell therapies have transformed the treatment landscape of multiple hematologic malignancies since they first rose to prominence, but they are associated with a high financial cost, both for the patient and the health care institution that provides them.

Media Training Helps Investigators, Institutions Shine

March 13th 2023

Here are 5 tips and tricks to help you shine when the spotlight is on you.

Adding AI Analysis to Targeted Transcriptome Represents Potential Aid for Differential Diagnosis

March 1st 2023

As artificial intelligence in cancer care continues to be better understood and refined, the number of potential clinical applications is rapidly expanding.

Prior Authorization Hurdles Delay Oncology Care

December 27th 2022

Prior authorization on cancer treatments is delaying patient care, affecting outcomes, and diverting providers from patient care according to results of a survey conducted by the Association for Clinical Oncology.

Effective Communication on HPV Vaccination Benefits Is Needed

November 29th 2022

Several articles in a recent issue of the high-impact journal Science highlight areas of concern in the scientific community that may have detrimental effects on communications regarding the human papillomavirus vaccination as a cancer prevention strategy.

Building the Optimal Patient Experience Takes Planning and Effort

November 22nd 2022

Ensuring a positive patient experience should be a top priority throughout the entire treatment journey, as higher patient satisfaction can drive improved health outcomes, treatment adherence, and quality of life.

Practices Should Refocus Efforts on Helping Patients Address Financial Toxicities

November 2nd 2022

Optimizing clinical pathways to address financial toxicities faced by patients with cancer requires a complex, multifaceted approach. However, even small in-practice changes may ease the financial burdens and improve outcomes.

Cost Minimization Relies on Sequencing in Metastatic Breast Cancer

October 11th 2022

Sequencing complexities with chemotherapy-based regimens in metastatic breast cancer pose unique challenges for valuebased decision-making in routine practice.

Benchmarks in Clinical Trial Design Require Closer Examination by Oncologists

September 14th 2022

Maurie Markman, MD, elaborates on the need to take a closer look at the benchmarks used in clinical trial designs in oncology.

Implementation Research Takes On an Increasingly Essential Role in Oncology

August 29th 2022

The publication of the objectively meaningful outcomes in high-impact peer-reviewed medical journals does not necessarily result in the observations being implemented into routine clinical care.

Is War a Good Metaphor for Cancer Care?

August 10th 2022

The National Cancer Act of 1971 introduced the concept of a “war on cancer,” which has since affected the language we use when discussing the disease.

Errors in Primary Payer Data Persist in Cancer Registries

August 10th 2022

Primary payer data reported by cancer registries are subject to measurement error and can result in biased estimates of insurance-related policy effects.